@pdrpuff1 @opsoms I think Covaxin is 3 shots as well. BB mentioned it was similar to the polio vax in that 3 shots were required for pediatric lifelong immunity.
@Ocugen I wonder why Bharat Biotech is developing a new “variant proof” vaccine when the data for Covaxin shows it to be variant proof already. Is it possible India’s infatuation with pride led its phase 3 study to inflate those efficacy numbers? Maybe that’s why the FDA rejected it.
@Ocugen “We are very disappointed in the FDA’s decision to reject our pediatric EUA application” what do you think would happen when you submitted data from a 500 child sample size study? Even india hadn’t approved it at that point. Borderline scam.
@Ocugen Conveniently giving no updates on the Tech Transfer. Signing letters of intent like you have the money to buy anything right now. Going to burn through that 130 million pretty quick.
@Ocugen Imagine “blindly” (lol) hiring 60 new people when you have no path to revenue. Copying and pasting Pfizer job applications. Just preparing for the inevitable lawsuits so they can say “Look, we tried! See?”
@Ocugen Having brought Prevnar 13 to market, one would think Shankar would know a lot about EUA. That’s true. He does. And he knew Covaxin didn’t stand a chance from the start.